NEW HOPE, Pa., June 1 /PRNewswire-FirstCall/ -- Protalex, Inc.
(OTC Bulletin Board: PRTX) announced today that Steven H. Kane, President and
Chief Executive Officer of Protalex, Inc. will present at the Pacific Growth
Equities 2005 Life Sciences Conference at the Intercontinental Mark Hopkins
Hotel in San Francisco, CA.
Mr. Kane is scheduled to speak on Tuesday, June 7, 2005 at 9:30AM Pacific
About Protalex, Inc.
Protalex is a biotechnology company engaged in the development of a new
class of drug for the treatment of Rheumatoid Arthritis, Pemphigus and other
Protalex assumes no obligation to update any forward-looking statements or
information set forth in its Press Releases. Protalex's actual results could
differ materially from those described in Protalex's Press Releases. Factors
that could cause or contribute to such differences include, but are not
limited to, those discussed in detail under the heading "Risk Factors" in
Protalex's Post Effective Amendment No. 3 to the Registration Statement on
Form SB-2 filed with the SEC on March 15, 2005 and other periodic reports
filed with the SEC. These risks should be considered only in connection with
the fully discussed risks and other factors discussed in detail in the
aforementioned registration statement and Protalex, Inc.'s other periodic
reports filed with the SEC.
SOURCE Protalex, Inc.